Trial intelligence / Profile preview

Controlled Trial of Risperidone and Divalproex Sodium in Pediatric Bipolar

NCT00176202Phase 3Completed

Sponsor
University of Illinois Chicago
Start
Apr 2003
Primary completion
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of risperidone in bipolar disorder (BD), sponsored by University of Illinois Chicago. Started Apr 2003; status: completed.

02

Drugs

risperidone
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00176202.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00176202.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call